Differences

This shows you the differences between two versions of the page.

--- robyn_harrison [2022/03/29 15:35]
liam [University of Alberta]
+++ robyn_harrison [2022/03/29 16:58] (current)
liam [COVID-19]
@@ Line 3: / Line 3: @@
 {{ ::dr_harrison_8-e1598373087118-250x250.jpeg?150|}}
-Dr. **Robyn Alana Harrison**, MD, MSc, FRCPC, is a Canadian [[infectious diseases]] specialist based in Edmonton, Alberta. She speaks English and French.
+Dr. **Robyn Alana Harrison**, MD, MSc, FRCPC, is a Canadian [[infectious diseases]] specialist based in Edmonton, Alberta. She speaks English and French.((//Doctor Harrison Robyn Alana Infectious diseases specialist in Edmonton.// Doctor of Alberta. Retrieved March 21, 2022, from https://archive.ph/XfnWc))
 She is notable in the [[COVID-19 pandemic]] due to her role as Vice-chair of the [[National Advisory Committee on Immunization]] (NACI).
@@ Line 15: / Line 15: @@
 ==== University of Alberta ====
-Dr. Harrison is a Clinical Professor in the Faculty of Medicine & Dentistry at the [[University of Alberta]]. She also practices at the [[University of Alberta Hospital]], at least as recently as 2014.
+Dr. Harrison is a Clinical Professor in the Faculty of Medicine & Dentistry at the [[University of Alberta]].((//Robyn Harrison, MD, MSc, FRCPC.// Directory@UAlberta; University of Alberta. Retrieved March 21, 2022, from https://archive.ph/Rdb4X)) She also practices at the [[University of Alberta Hospital]], at least as recently as 2014.((//The AATHP Annual Travel Health Symposium & General Meeting 2014 (p. 3).// (2014). Alberta Association of Travel Health Professionals. https://web.archive.org/web/20220321181523/http://aathp.com/AATHP_conf_2014.pdf))
-The U of A Hospital is funded through the [[University Hospital Foundation]] by [[pharmaceutical_companies:Astellas Pharma]], [[Bell Media]], [[pharmaceutical_companies:Biogen]], [[pharmaceutical_companies:BIOTECanada]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Canadian National Railway]] (a [[Bill Gates|Bill]] and [[Melinda Gates|Melinda]] Gates company), [[Corus Entertainment]], [[CTV]], [[Cystic Fibrosis Canada]], [[Deloitte]], [[Ernst & Young LLP]], [[Fidelity Investments]], [[Global News]], [[pharmaceutical_companies:Janssen]], [[KPMG]], [[London Drugs]], [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Novo Nordisk]], [[PricewaterhouseCoopers]], [[RBC (Royal Bank of Canada)]]/RBC Foundation, [[pharmaceutical_companies:Roche]], [[Scotiabank]], [[pharmaceutical_companies:Servier]], [[Suncor Energy]], [[Sun Life Financial]], [[pharmaceutical_companies:Takeda]], [[TELUS]], [[University of Calgary]], [[Volvo]], and [[WestJet]]., ,
+The U of A Hospital is funded through the [[University Hospital Foundation]] by [[pharmaceutical_companies:Astellas Pharma]], [[Bell Media]], [[pharmaceutical_companies:Biogen]], [[pharmaceutical_companies:BIOTECanada]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Canadian National Railway]] (a [[Bill Gates|Bill]] and [[Melinda Gates|Melinda]] Gates company), [[Corus Entertainment]], [[CTV]], [[Cystic Fibrosis Canada]], [[Deloitte]], [[Ernst & Young LLP]], [[Fidelity Investments]], [[Global News]], [[pharmaceutical_companies:Janssen]], [[KPMG]], [[London Drugs]], [[medical_technology_companies:Medtronic]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Novo Nordisk]], [[PricewaterhouseCoopers]], [[RBC (Royal Bank of Canada)]]/RBC Foundation, [[pharmaceutical_companies:Roche]], [[Scotiabank]], [[pharmaceutical_companies:Servier]], [[Suncor Energy]], [[Sun Life Financial]], [[pharmaceutical_companies:Takeda]], [[TELUS]], [[University of Calgary]], [[Volvo]], and [[WestJet]].((Abbott, J. L. (2021). //Thank you to our donors.// University Hospital Foundation. https://web.archive.org/web/20220128195634/https://givetouhf.ca/app/uploads/2021/12/UHF-2021-HonouringDonors-WEB-v2.pdf)) ((Abbott, J. L. (2020). //Annual Report 2019-2020.// University Hospital Foundation. https://web.archive.org/web/20220109041602/https://givetouhf.ca/app/uploads/2021/08/UHF_Annual-Report-2019-2020-Revised_19412_F-pages-smaller.pdf)) ((Brown, J. (2019). //Annual Report 2018-2019.// University Hospital Foundation. https://web.archive.org/web/20220109041607/https://givetouhf.ca/app/uploads/2020/10/UHF-Annual-Report-2018-19-lowres.pdf))
-Many of these are member organizations of the World Economic Forum, and the others listed have been demonstrated to have a degree of conflict of interest (real or perceived) in influencing the COVID-19 pandemic response. This includes financial institutions, pharmaceutical companies, and media.
+Many of these are member organizations of the [[World Economic Forum]], and the others listed have been demonstrated to have a degree of conflict of interest (real or perceived) in influencing the [[COVID-19 pandemic]] response.((//Partners.// World Economic Forum. Retrieved March 21, 2022, from https://web.archive.org/web/20220319000719/https://www.weforum.org/partners)) This includes [[financial institutions]], [[pharmaceutical companies]], and [[media]].
 ==== Covenant Health ====
-Dr. Harrison practices medicine as an infectious diseases and internal medicine specialist at Grey Nuns Community Hospital under Covenant Health.,  She also served as consultant for the Covenant Health Alberta Occupational Health and Safety Program from 2008-2014.
+Dr. Harrison practices medicine as an infectious diseases and internal medicine specialist at [[Grey Nuns Community Hospital]] under [[Covenant Health]].((//Dr. Harrison - Doctor Robyn Alana Harrison - 2275-1100 Youville Drive West NW Grey Nuns Hospital, Edmonton, Alberta.// Alberta Doctor Directory. Retrieved March 21, 2022, from https://archive.ph/rGesh)) ((//Grey Nuns Community Hospital.// Alberta Health Services. Retrieved March 21, 2022, from https://archive.ph/sZQ4e)) She also served as consultant for the Covenant Health Alberta Occupational Health and Safety Program from 2008-2014.
 ==== Alberta Health Services (2009-current) ====
-Dr. Harrison is a Communicable Disease Consultant for the province-wide Alberta Health Services Workplace Health and Safety Program, a position she has held since 2009. In this role, she co-authored an open letter addressing concerns and “misinformation” about the safety of the COVID-19 injections alongside members of the AHS Scientific Advisory Group, including Lynora Saxinger and John Conly. The letter was published on October 1st, 2021.
+Dr. Harrison is a Communicable Disease Consultant for the province-wide [[public_health_agencies:canada:Alberta Health Services]] Workplace Health and Safety Program, a position she has held since 2009. In this role, she co-authored an open letter addressing concerns and “[[misinformation]]” about the safety of the [[:COVID-19_vaccines|COVID-19 injections]] alongside members of the AHS Scientific Advisory Group, including [[:public_health_agencies:canada:Lynora Saxinger]] and [[:public_health_agencies:canada:John Conly]].((Constantinescu, C., Kellner, J. D., Conly, J., Klein, K., Saxinger, L. M., Wickland-Weller, M., Harrison, R., & Smith, S. W. (2021). //An open letter in response to vaccine concerns and misinformation.// Alberta Health Services. https://web.archive.org/web/20220321163612/https://www.albertahealthservices.ca/assets/news/nr/ne-nr-2021-10-01-response-vaccine-concerns-misinformation.pdf)) The letter was published on October 1st, 2021.
 ==== Alberta Advisory Committee on Immunization (2015-present) ====
-Dr. Harrison is a member of the Alberta Advisory Committee on Immunization, and she participates in infection prevention working groups in the province of Alberta, including past work on pandemic influenza H1N1 in 2009, and avian influenza is 2014.
+Dr. Harrison is a member of the [[Alberta Advisory Committee on Immunization]], and she participates in infection prevention working groups in the province of Alberta, including past work on pandemic influenza [[H1N1]] in 2009, and [[avian influenza]] in 2014.
 ==== Royal Society of Canada ====
-Dr. Harrison was recruited to the RSC Task Force on COVID-19 by the President of the Royal Society of Canada in April 2020. The group was established to rapidly create policy briefings. In February 2021, she co-authored a report titled “The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era.”
+Dr. Harrison was recruited to the [[royal_society_of_canada:RSC Task Force on COVID-19]] by the President of the [[Royal Society of Canada]] in April 2020. The group was established to rapidly create policy briefings. In February 2021, she co-authored a report titled “The Epidemiology of COVID-19 in Canada in 2020: The Pre-Vaccine Era.”((Sligl, W., Waldner, D., Johnstone, J., Harrison, R., Webster, D., & Saxinger, L. (2021, February). //The epidemiology of COVID-19 in Canada in 2020: the pre-vaccine era.// Royal Society of Canada. https://www.interacademies.org/sites/default/files/2021-02/Epid%20PB_EN.pdf))
+==== National Advisory Committee on Immunization (2017-current) ====
-==== National Advisory Committee on Immunization (2017-current) ====
+Dr. Harrison began as a member of the [[National Advisory Committee on Immunization]] (NACI) in September 2017, and has served as Chair of the [[Hepatitis]] and [[Influenza]] working groups.((Public Health Agency of Canada. (2021, June 15). //Statement from the Public Health Agency of Canada Announcing the New Chair and Vice-Chair of the National Advisory Committee on Immunization.// Direct Source News; Wayback Machine. https://archive.ph/YBohl)) On December 19, 2020, she delivered a presentation hosted by [[CANVax]] and the [[National Collaborating Centre for Infectious Diseases]] to inform health care workers about NACI’s [[Pfizer-BioNTech COVID-19 vaccine]] recommendations.((NCCID. (2020, December 11). //Recommendations of the National Advisory Committee on Immunization (NACI) on the use of the Pfizer-BioNTech COVID-19 vaccine.// National Collaborating Centre for Infectious Diseases. https://archive.ph/StT0O)) ((NCCID • CCNMI. (2020, December 19). //Recommendations of NACI on the Use of the Pfizer BioNTech COVID 19 Vaccine.// YouTube. https://www.youtube.com/watch?v=0sE-si0XW3k)) She was appointed as the Vice-chair of NACI in June 2021.((Public Health Agency of Canada. (2021, June 7). //Statement from the Public Health Agency of Canada Announcing the New Chair and Vice-Chair of the National Advisory Committee on Immunization.// Government of Canada. https://archive.ph/rWLid)) On June 18, she participated in a French language webinar for the [[Canadian Association of Physician Assistants]] on the topic of [[COVID-19 vaccines|COVID-19 vaccine]] interchangeability.((//Upcoming Events CAPA - ACAM NACI Recommendations on COVID-19 Vaccine Interchangeability.// (2021, June 18). Canadian Association of Physician Assistants. https://archive.ph/O1LY8))
-Dr. Harrison began as a member of the National Advisory Committee on Immunization in September 2017, and has served as Chair of the Hepatitis and Influenza working groups. On December 19, 2020, she delivered a presentation hosted by CANVax and the National Collaborating Centre for Infectious Diseases to inform health care workers about NACI’s Pfizer-BioNTech COVID-19 vaccine recommendations.,  She was appointed as the Vice-chair of NACI in June 2021. On June 18, she participated in a French language webinar for the Canadian Association of Physician Assistants on the topic of COVID-19 vaccine interchangeability.
+On October 27, 2021, she participated in a webinar discussing flu shots in the 2021/2022 influenza season.((//PHAC webinar for health care providers: seasonal influenza immunization 2021-2022.// (2021, October 20). National Collaborating Centre for Infectious Diseases. https://archive.ph/OhdMH )) The video, posted to the [[YouTube]] channel for the National Collaborating Centre for Infectious Diseases, reveals that the [[Public Health Agency of Canada]] and NACI were aiming for an 80% rate of flu vaccine uptake.((NCCID • CCNMI. (2021, November 29). //PHAC Webinar for Health Care Providers: Seasonal Influenza Immunization 2021-2022.// YouTube. https://web.archive.org/web/20220321165148/https://www.youtube.com/watch?v=Mlg0YDT9nRg))
-On October 27, 2021, she participated in a webinar discussing flu shots in the 2021/2022 influenza season. The video, posted to the YouTube channel for the National Collaborating Centre for Infectious Diseases, reveals that the Public Health Agency of Canada and NACI were aiming for an 80% rate of flu vaccine uptake.
 She has received repayment for travel expense totalling less than $1,000 from PHAC since 2017.
@@ Line 50: / Line 49: @@
 ==== Antimicrobial Resistance ====
-Dr. Harrison is an Editorial Contributor/Reviewer for an antimicrobial resistance project called Bugs & Drugs. Other team members include:
+Dr. Harrison is an Editorial Contributor/Reviewer for an [[antimicrobial resistance]] project called [[Bugs & Drugs]].((//B&D - The App.// Bugs and Drugs. Retrieved March 24, 2022, from https://archive.ph/h9lq7)) Other team members include:
-  * John Conly of the AHS Scientific Advisory Group for COVID-19
+  * [[public_health_agencies:canada:John Conly of the AHS Scientific Advisory Group for COVID-19
-  * Andrew Morris of the Ontario COVID-19 Science Advisory Table
+  * [[public_health_agencies:canada:Andrew Morris]] of the [[Ontario COVID-19 Science Advisory Table]]
-  * Lynora Saxinger of the AHS Scientific Advisory Group for COVID-19
+  * [[public_health_agencies:canada:Lynora Saxinger]] of the AHS Scientific Advisory Group for COVID-19
-The project was funded by Alberta Health Services, Alberta Health, and the BC Ministry of Health, Pharmaceutical Services Division.
+The project was funded by [[public_health_agencies:canada:Alberta Health Services]], [[Alberta Health]], and the [[BC Ministry of Health]], Pharmaceutical Services Division.
 ==== COVID-19 ====
-Dr. Harrison is a site investigator for Canadian COVID-19 Cohort Study (CCCS), studying the epidemiology of COVID-19 in Canadian healthcare workers. The specific items for research include the rate of COVID-19 infection, risk factors for infection (occupational and community), antibody levels over time, uptake of vaccines against COVID-19, and psychological impact of working during a pandemic. Dr. Harrison’s study group includes staff working at either Grey Nuns Community Hospital or the University of Alberta Hospital.
+Dr. Harrison is a site investigator for [[Canadian COVID-19 Cohort Study]] (CCCS), studying the epidemiology of [[COVID-19]] in Canadian healthcare workers.((//Edmonton - Canadian COVID-19 Cohort Study (CCCS): Study of the epidemiology of COVID-19 in Canadian healthcare workers.// TIBDN: Toronto Invasive Bacterial Diseases Network. Retrieved March 21, 2022, from https://archive.ph/3u0sv)) The specific items for research include the rate of COVID-19 infection, risk factors for infection (occupational and community), antibody levels over time, uptake of [[vaccines]] against COVID-19, and psychological impact of working during a [[pandemic]]. Dr. Harrison’s study group includes staff working at either [[Grey Nuns Community Hospital]] or the [[University of Alberta Hospital]].
-The CCCS study page bearing Dr. Harrison’s name is hosted on the website for the Toronto Invasive Bacterial Diseases Network at Mount Sinai Hospital, which is funded by “an unrestricted educational grant from Pfizer Canada Inc.”
+The CCCS study page bearing Dr. Harrison’s name is hosted on the website for the [[Toronto Invasive Bacterial Diseases Network]] at [[Mount Sinai Hospital]], which is funded by “an unrestricted educational grant from [[pharmaceutical_companies:Pfizer|Pfizer Canada Inc]].”